Data Construction Project for Artificial Intelligence Learning: Chest Auscultation Sound Data

NCT ID: NCT05320900

Last Updated: 2023-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose is to establish chest auscultation data and related clinical data for diagnosing heart and lung diseases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The incidence of cardiovascular diseases worldwide is steadily increasing. According to the report of the American Heart Association, there were 271 million cardiovascular diseases in 1990, and 523 million cases in 2019, about doubling in 30 years. The number of deaths due to cardiovascular disease is also steadily increasing from 12.1 million in 1990 to 18.6 million in 2019.

Physical examination, which is the most basic skill in patient care, consists of inspection, auscultation, percussion, and palpation. Among them, auscultation is the most widely used test in all areas where a stethoscope is used, and it is a basic examination that is essential from primary medical institutions to tertiary medical institutions for non-invasive initial diagnosis in patients complaining of chest symptoms.

However, if a specialist in the field with a lot of experience does not interpret it carefully, it is difficult to make a decision, and the deviation of the test results is large, so a significant number of patients depend on expensive follow-up tests (ultrasound, CT, MRI, etc.) This leads to a vicious cycle of incurring costs and unnecessary treatment.

Recently, with the development of machine learning techniques, computing technologies, and artificial intelligence (AI) based on a lot of data, various learning technologies are applied as tools for disease diagnosis and prognosis prediction in medicine.

Through machine learning-based chest auscultation sound analysis, there is an expectation that disease diagnosis and prognosis prediction will be able to overcome differences and interpretations by examiners. It can be very helpful in preventing overuse of tests and reducing medical costs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Auscultation for Clinical Evaluation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Severance hospital

Cardiovascular disease patients

Chest auscultation

Intervention Type DIAGNOSTIC_TEST

Chest auscultation data

Yongin Severance hospital

Cardiovascular disease patients

Chest auscultation

Intervention Type DIAGNOSTIC_TEST

Chest auscultation data

Soon Chun Hyang University Hospital Bucheon

Cardiovascular disease patients

Chest auscultation

Intervention Type DIAGNOSTIC_TEST

Chest auscultation data

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chest auscultation

Chest auscultation data

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults who are 20 years and older

Exclusion Criteria

* Patient refusal
* Uncertain radiographs
* Uncertain tests results
Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hyuk-Jae Chang

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hyuk-Jae Chang, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Severance Hospital, Yonsei University College of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yongin Severance Hospital

Yŏngin, Giheung-gu, South Korea

Site Status

Soonchunhyang University Bucheon Hospital

Bucheon-si, , South Korea

Site Status

Severance Hospital

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AI-sound

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.